To study neonatal bleeding disorders, transgenic mice (TgAlb-uPA) carrying a tandem array of about four Albumin promoter/enhancer-driven urokinase-type plasminogen activator (uPA) genes were created [12]. Here, PLAU is linked to hemorrhagic disease.